K. Mun˜iz
FULL PAPER
127.79, 131.70, 146.99, 173.38 ppm. IR (KBr): ν˜ ϭ 2968, 2937,
2899, 1751, 1489, 1463, 1360, 1234, 1193, 1174, 1109, 1011, 868
cmϪ1. MS (EI, eV): m/z (%) ϭ 675 (13) [M]ϩ, 602 (100), 546 (22),
490 (21), 224 (12), 57 (24). HRMS: calcd. for C23H38BrN3O3188Os:
671.1655; found 671.1652.
(1)
Ethyl
[(2R,4S,5R)/(2S,4R,5S)]-trans-5-(4Ј-Bromophenyl)-1,3-bis-
(tert-butyl)-2-tert-butylimido-2-oxo-2-osma(VI)imidazolidine-4-
carboxylate (38): M.p. 68 °C (dec.). 1H NMR (300 MHz, C6D6):
δ ϭ 1.12 (t, J ϭ 7.1 Hz, 3 H), 1.17 (s, 9 H), 1.24 (s, 9 H), 1.36 (s,
9 H), 4.07 (q, J ϭ 7.1 Hz, 2 H), 4.27 (d, J ϭ 0.6 Hz, 1 H), 4.95 (s,
1 H), 6.86 (d, J ϭ 8.3 Hz, 2 H), 7.25 (d, J ϭ 8.3 Hz, 2 H) ppm.
13C NMR (75 MHz, C6D6): δ ϭ 14.27, 30.35, 31.70, 32.35, 61.03,
64.35, 64.50, 69.86, 83.50, 86.01, 121.47, 128.88, 131.14, 145.79,
174.44 ppm. IR (KBr): ν˜ ϭ 2970, 2931, 2870, 1747, 1718, 1635,
1234, 1191, 1105, 1011, 891 cmϪ1. MS (EI, eV): m/z (%) ϭ 675 (11)
[M]ϩ, 602 (100), 546 (23), 490 (29), 182 (18), 57 (18). HRMS: calcd.
for C23H38BrN3O3188Os: 671.1655; found 671.1655.
The final Hammett correlation as depicted in Figure 4 was ob-
tained employing standard sr values.[34]
Diaminations of Ethyl Cinnamates with Tris(imido) Reagent 4: Di-
aminations of ethyl cinnamates were carried out following the gen-
eral procedure for diamination reactions outlined above.
Diamination of Ethyl 4Ј-Methoxycinnamate: This reaction was car-
ried out according to the general procedure with ethyl 4Ј-methoxy-
cinnamate (72 mg, 0.3 mmol) and the tris(imido) compound 4
(105 mg, 0.25 mmol). Purification by column chromatography
(ethyl acetate/hexanes, 1:3, v/v) gave two fractions that contained
the pure diastereomers (82% combined yield, 59:41 diastereomeric
ratio).
Diamination of Ethyl Cinnamate: This was carried out with ethyl
cinnamate (53 mg, 0.3 mmol) and the tris(imido) compound 4
(105 mg, 0.25 mmol) according to the general procedure. Purifi-
cation by column chromatography (ethyl acetate/hexanes, 1:5, v/
v) gave two fractions that contained the pure diastereomers (93%
combined yield, 58:42 diastereomeric ratio).
Ethyl [(2R,4R,5S)/(2S,4S,5R)]-trans-1,3-Bis(tert-butyl)-2-tert-butyl-
imido-5-(4Ј-methyloxophenyl)-2-oxo-2-osma(VI)imidazolidine-4-
carboxylate (35): M.p. 89 °C (dec.). 1H NMR (300 MHz, C6D6):
δ ϭ 1.00 (t, J ϭ 7.1 Hz, 3 H), 1.22 (s, 9 H), 1.37 (s, 9 H), 1.60 (s,
9 H), 3.30 (s, 3 H), 3.93 (q, J ϭ 7.1 Hz, 2 H), 4.43 (s, 1 H), 5.02
(s, 1 H), 6.79Ϫ7.60 (m, 5 H) ppm. 13C NMR (75 MHz, C6D6): δ ϭ
14.11, 30.15, 32.09, 33.61, 61.29, 62.07, 65.17, 77.06, 77.94, 81.25,
84.82, 125.98, 128.43, 137.28, 142.31, 172.37 ppm. IR (KBr): ν˜ ϭ
2958, 2854, 1629, 1456, 1385, 1113, 894, 798 cmϪ1. MS (EI, eV):
m/z (%) ϭ 625 (2) [M]ϩ, 567 (3), 316 (39), 149 (62), 135 (100), 57
(97). HRMS: calcd. for C24H41N3O4188Os: 623.2656; found
623.2650.
Ethyl [(2R,4R,5S)/(2S,4S,5R)]-trans-1,3-Bis(tert-butyl)-2-tert-butyl-
imido-2-oxo-5-phenyl-2-osma(VI)imidazolidine-4-carboxylate (39):
M.p. 88 °C (dec.). 1H NMR (300 MHz, C6D6): δ ϭ 0.99 (t, J ϭ
7.2 Hz, 3 H), 1.01 (s, 9 H), 1.33 (s, 9 H), 1.59 (s, 9 H), 3.93 (q, J ϭ
7.2 Hz, 2 H), 4.43 (d, J ϭ 0.4 Hz, 1 H), 5.02 (s, 1 H), 7.02Ϫ7.22
(m, 3 H), 7.62Ϫ7.69 (m, 2 H) ppm. 13C NMR (75 MHz, C6D6):
δ ϭ 14.31, 30.52, 31.41, 32.96, 60.65, 63.92, 65.15, 69.50, 81.69,
86.78, 127.26, 127.47, 127.85, 128.56, 148.08, 173.67 ppm. IR
(KBr): ν˜ ϭ 2968, 2931, 1751, 1462, 1363, 1232, 1194, 1161, 1105,
877 cmϪ1. MS (EI, eV): m/z (%) ϭ 597 (10) [M ϩ 1]ϩ, 469 (38),
413 (52), 357 (29), 146 (22), 57 (100). HRMS: calcd. for
C23H39N3O3188Os: 593.2551; found 593.2555.
Ethyl [(2R,4S,5R)/(2S,4R,5S)]-trans-1,3-Bis(tert-butyl)-2-tert-butyl-
imido-5-(4Ј-methyloxophenyl)-2-oxo-2-osma(VI)imidazolidine-4-
carboxylate (36): M.p. 93 °C (dec.). 1H NMR (300 MHz, C6D6):
δ ϭ 1.63 (t, J ϭ 7.0 Hz, 3 H), 1.25 (s, 9 H), 1.35 (s, 9 H), 1.45 (s,
9 H), 3.31 (s, 3 H), 4.12 (q, J ϭ 7.0 Hz, 2 H), 4.45 (d, J ϭ 0.6 Hz,
1 H), 5.14 (s, 1 H), 6.75Ϫ7.42 (m, 5 H) ppm. 13C NMR (75 MHz,
C6D6): δ ϭ 15.73, 30.89, 31.06, 33.34, 60.99, 62.72, 64.09, 76.91,
78.02, 80.60, 84.34, 126.35, 128.54, 137.52, 142.11, 170.99 ppm. IR
(KBr): ν˜ ϭ 3071, 1961, 1936, 1743, 1654, 1473, 1389, 1109, 874,
802 cmϪ1. MS (EI, eV): m/z (%) ϭ 625 (1) [M]ϩ, 567 (3), 316 (23),
149 (57), 135 (88), 57 (100). HRMS: calcd. for C24H41N3O4188Os:
623.2656; found 623.2652.
Ethyl [(2R,4S,5R)/(2S,4R,5S)]-trans-1,3-Bis(tert-butyl)-2-tert-butyl-
imido-2-oxo-5-phenyl-2-osma(VI)imidazolidine-4-carboxylate (40):
M.p. 95 °C (dec.). 1H NMR (300 MHz, C6D6): δ ϭ 1.15 (t, J ϭ
7.1 Hz, 3 H), 1.21 (s, 9 H), 1.31 (s, 9 H), 1.45 (s, 9 H), 4.09 (q, J ϭ
7.1 Hz, 2 H), 4.41 (d, J ϭ 0.7 Hz, 1 H), 5.13 (s, 1 H), 7.05Ϫ7.33
(m, 5 H) ppm. 13C NMR (75 MHz, C6D6): δ ϭ 14.30, 30.42, 31.74,
32.41, 60.93, 64.45, 64.61, 69.66, 84.32, 86.25, 126.76, 127.10,
128.86, 146.74, 174.66 ppm. IR (KBr): ν˜ ϭ 3389, 2954, 2922, 1761,
1458, 1352, 1209, 1201, 1187, 1158, 1101, 1030, 876 cmϪ1. MS (EI,
eV): m/z (%) ϭ 597 (1) [M ϩ 1]ϩ, 524 (2) 469 (12), 413 (17), 355
(9), 146 (29), 57 (100). HRMS: calcd. for C23H39N3O3188Os:
593.2551; found 593.2549.
Diamination of Ethyl 4Ј-Bromocinnamate: This was carried out with
ethyl 4Ј-bromocinnamate (77 mg, 0.3 mmol) and the tris(imido)
compound 4 (105 mg, 0.25 mmol) according to the general pro-
cedure. Purification by column chromatography (ethyl acetate/hex-
anes, 1:3, v/v) gave two fractions that contained the pure dia-
stereomers (88% combined yield, 61:39 diastereomeric ratio).
Diamination of Ethyl 4Ј-Methylcinnamate: This was carried out
with ethyl 4Ј-methylcinnamate (67 mg, 0.3 mmol) and the tris(im-
ido) compound 4 (105 mg, 0.25 mmol) according to the general
procedure. Purification by column chromatography (ethyl acetate/
hexanes, 1:4, v/v) gave two fractions that contained the pure dia-
stereomers (89% combined yield, 58:42 diastereomeric ratio).
Ethyl
(tert-butyl)-2-tert-butylimido-2-oxo-2-osma(VI)imidazolidine-4- Ethyl [(2R,4R,5S)/(2S,4S,5R)]-trans-1,3-Bis(tert-butyl)-2-tert-butyl-
carboxylate (37): M.p. 64 °C (dec.). 1H NMR (300 MHz, C6D6):
imido-5-(4Ј-methylphenyl)-2-oxo-2-osma(VI)imidazolidine-4-
[(2R,4R,5S)/(2S,4S,5R)]-trans-5-(4Ј-Bromophenyl)-1,3-bis-
1
δ ϭ 0.97 (t, J ϭ 7.1 Hz, 3 H), 1.14 (s, 9 H), 1.27 (s, 9 H), 1.57 (s, carboxylate (41): M.p. 101 °C (dec.). H NMR (300 MHz, C6D6):
9 H), 3.89 (q, J ϭ 7.1 Hz, 1 H), 3.90 (q, J ϭ 7.1 Hz, 1 H), 4.28 (s, δ ϭ 0.98 (t, J ϭ 7.0 Hz, 3 H), 1.21 (s, 9 H), 1.35 (s, 9 H), 1.59 (s,
1 H), 4.83 (s, 1 H), 7.29 (d, J ϭ 7.9 Hz, 2 H), 7.30 (d, J ϭ 7.9 Hz, 9 H), 3.91 (q, J ϭ 7.0 Hz, 2 H), 4.45 (d, J ϭ 0.4 Hz, 1 H), 5.04 (s,
2 H) ppm. 13C NMR (75 MHz, C6D6): δ ϭ 14.29, 30.47, 31.37, 1 H), 7.04 (d, J ϭ 7.9 Hz, 2 H), 7.10Ϫ7.18 (m, 2 H) ppm. 13C NMR
32.88, 60.75, 63.83, 65.05, 69.67, 80.89, 86.44, 121.43, 129.08, (75 MHz, C6D6): δ ϭ 14.32, 21.02, 30.54, 31.46, 33.00, 60.63, 63.94,
2250
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2004, 2243Ϫ2252